US Patent 8034771 IL-1F6 polypeptides
Patent 8034771 was granted and assigned to Amgen on October, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+111 characters)
Article
Patent abstract
The present invention provides compositions and methods relating to IL-1Rrp2 requiring proteins.
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08034771 IL-1F6 polypeptides US Patent 8034771 IL-1F6 polypeptides
Infobox
Patent Number
0803477100
Patent Number
803477100
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080347710
Date of Patent
October 11, 2011
0Patent Application Number
119002350
Date Filed
September 10, 2007
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080347710
Date of Patent
October 11, 2011
0Patent Application Number
119002350
Date Filed
September 10, 2007
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08034771 IL-1F6 polypeptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08034771
Date of patent
October 11, 2011
Patent application number
11900235
Date Filed
September 10, 2007
Patent primary examiner
Find more entities like US Patent 8034771 IL-1F6 polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
